ZNTL

NASDAQStock

Zentalis Pharmaceuticals, Inc.

$2.69-0.06 (-2.18%)

52-Week Range

$1.04

$3.74

Key Stats

Market Cap

194.4M

P/E Ratio

—

Dividend Yield

—

Beta

1.71

Volume

345.9K

Avg Volume

805.6K

Performance

+17.52%

+96.43%

+89.66%

YTD

+100.73%

+55.37%

-85.47%

-94.00%

Price Chart

ETF Exposure

ZNTL is held by 13 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.04%	156,150	$462K	$1.27B	0.60%
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.02%	190,486	$564K	$2.67B	0.34%
FESM	FIDELITY ENHANCED SMALL CAP ETF	0.02%	228,642	$700K	$4.11B	0.28%
AVSC	Avantis U.S. Small Cap Equity ETF	0.01%	42,243	$116K	$2.36B	0.25%
DFAS	Dimensional - US Small Cap ETF	0.00%	81,063	$223K	$12.65B	0.26%
VHT	Vanguard Health Care ETF	0.00%	152,710	$371K	$19.80B	0.09%
VXF	Vanguard Extended Market ETF	0.00%	543,757	$1.3M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	83	$274	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,976	$10K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	14	$47	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,694,426	$4.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	8,912	$29K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	768	$3K	$1.29B	0.17%

About ZNTL ETF Exposure

Zentalis Pharmaceuticals, Inc. (ZNTL) is held by 13 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 194.4M, ZNTL is a widely held institutional stock. The stock currently trades at $2.69. Investors can gain exposure to ZNTL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ZNTL, sorted by portfolio weight.